These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1362 related articles for article (PubMed ID: 24298908)

  • 1. Tumor glycolysis as a target for cancer therapy: progress and prospects.
    Ganapathy-Kanniappan S; Geschwind JF
    Mol Cancer; 2013 Dec; 12():152. PubMed ID: 24298908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
    Talekar M; Boreddy SR; Singh A; Amiji M
    Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.
    Gill KS; Fernandes P; O'Donovan TR; McKenna SL; Doddakula KK; Power DG; Soden DM; Forde PF
    Biochim Biophys Acta; 2016 Aug; 1866(1):87-105. PubMed ID: 27373814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
    Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
    Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.
    Ni X; Lu CP; Xu GQ; Ma JJ
    Acta Pharmacol Sin; 2024 Aug; 45(8):1533-1555. PubMed ID: 38622288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolytic genes in cancer cells are more than glucose metabolic regulators.
    Hu ZY; Xiao L; Bode AM; Dong Z; Cao Y
    J Mol Med (Berl); 2014 Aug; 92(8):837-45. PubMed ID: 24906457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolysis inhibition for anticancer treatment.
    Pelicano H; Martin DS; Xu RH; Huang P
    Oncogene; 2006 Aug; 25(34):4633-46. PubMed ID: 16892078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
    Granchi C; Fancelli D; Minutolo F
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment.
    Littleflower AB; Parambil ST; Antony GR; Subhadradevi L
    Biochimie; 2024 May; 220():107-121. PubMed ID: 38184121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor glycolysis by a mitotropic agent.
    Ganapathy-Kanniappan S
    Expert Opin Ther Targets; 2016; 20(1):1-5. PubMed ID: 26420565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer agents that counteract tumor glycolysis.
    Granchi C; Minutolo F
    ChemMedChem; 2012 Aug; 7(8):1318-50. PubMed ID: 22684868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cell metabolism: implications for therapeutic targets.
    Jang M; Kim SS; Lee J
    Exp Mol Med; 2013 Oct; 45(10):e45. PubMed ID: 24091747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic strategies targeting cancer--specific metabolism].
    Makinoshima H; Owada S; Esumi H
    Nihon Rinsho; 2015 Aug; 73(8):1296-301. PubMed ID: 26281681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
    Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
    J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
    Mathupala SP
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy metabolism transition in multi-cellular human tumor spheroids.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Avilés-Salas A; Marín-Hernández A; Carreño-Fuentes L; Maldonado-Lagunas V; Moreno-Sánchez R
    J Cell Physiol; 2008 Jul; 216(1):189-97. PubMed ID: 18264981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
    Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
    Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect.
    Chen XS; Li LY; Guan YD; Yang JM; Cheng Y
    Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.